Please use this identifier to cite or link to this item: https://hdl.handle.net/2440/130147
Citations
Scopus Web of Science® Altmetric
?
?
Full metadata record
DC FieldValueLanguage
dc.contributor.authorElovaris, R.A.-
dc.contributor.authorHajishafiee, M.-
dc.contributor.authorUllrich, S.S.-
dc.contributor.authorCe Fitzgerald, P.-
dc.contributor.authorLange, K.-
dc.contributor.authorHorowitz, M.-
dc.contributor.authorFeinle-Bisset, C.-
dc.date.issued2021-
dc.identifier.citationDiabetes Research and Clinical Practice, 2021; 171:1-8-
dc.identifier.issn0168-8227-
dc.identifier.issn1872-8227-
dc.identifier.urihttp://hdl.handle.net/2440/130147-
dc.description.abstractAIMS: In healthy individuals, intragastric administration of the branched-chain amino acids, leucine and isoleucine, diminishes the glycaemic response to a mixed-nutrient drink, apparently by stimulating insulin and slowing gastric emptying, respectively. This study aimed to evaluate the effects of leucine and isoleucine on postprandial glycaemia and gastric emptying in type-2 diabetes mellitus (T2D). METHODS: 14 males with T2D received, on 3 separate occasions, in double-blind, randomised fashion, either 10g leucine, 10g isoleucine or control, intragastrically 30 min before a mixed-nutrient drink (500 kcal; 74g carbohydrates, 18g protein, 15g fat). Plasma glucose, insulin and glucagon were measured from 30 min pre- until 120 min post-drink. Gastric emptying of the drink was also measured. RESULTS: Leucine and isoleucine stimulated insulin, both before and after the drink (all P<0.05; peak (mU/L): control: 70±15; leucine: 88±17; isoleucine: 74±15). Isoleucine stimulated (P<0.05), and leucine tended to stimulate (P=0.078), glucagon before the drink, and isoleucine stimulated glucagon post-drink (P=0.031; peak (pg/mL): control: 62±5; leucine: 70±9; isoleucine: 69±6). Neither amino acid affected gastric emptying or plasma glucose (peak (mmol/L): control: 12.0±0.5; leucine: 12.5±0.7; isoleucine: 12.0±0.6). CONCLUSIONS: In contrast to health, in T2D, leucine and isoleucine, administered intragastrically in a dose of 10 g, do not lower the glycaemic response to a mixed-nutrient drink. This finding argues against a role for 'preloads' of either leucine or isoleucine in the management of T2D.-
dc.description.statementofresponsibilityRachel A. Elovaris, Maryam Hajishafiee, Sina S. Ullrich, Penelope C.E. Fitzgerald,Kylie Lange, Michael Horowitz, Christine Feinle-Bisset-
dc.language.isoen-
dc.publisherElsevier-
dc.rights© 2020 Elsevier B.V. All rights reserved.-
dc.source.urihttp://dx.doi.org/10.1016/j.diabres.2020.108618-
dc.subjectBranched-chain amino acids-
dc.subjectblood glucose-
dc.subjectglucagon-
dc.subjectglucoregulatory hormones-
dc.subjecthuman-
dc.subjectinsulin-
dc.titleIntragastric administration of leucine and isoleucine does not reduce the glycaemic response to, or slow gastric emptying of, a carbohydrate-containing drink in type 2 diabetes-
dc.typeJournal article-
dc.identifier.doi10.1016/j.diabres.2020.108618-
dc.relation.granthttp://purl.org/au-research/grants/nhmrc/1103020-
dc.relation.granthttp://purl.org/au-research/grants/nhmrc/1158296-
pubs.publication-statusPublished-
dc.identifier.orcidLange, K. [0000-0003-3814-8513]-
dc.identifier.orcidHorowitz, M. [0000-0002-0942-0306]-
dc.identifier.orcidFeinle-Bisset, C. [0000-0001-6848-0125]-
Appears in Collections:Aurora harvest 4
Medicine publications

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.